157 related articles for article (PubMed ID: 19689342)
1. Targeting phosphatidylserine in anti-cancer therapy.
Kenis H; Reutelingsperger C
Curr Pharm Des; 2009; 15(23):2719-23. PubMed ID: 19689342
[TBL] [Abstract][Full Text] [Related]
2. Annexin A5: shifting from a diagnostic towards a therapeutic realm.
Kenis H; Hofstra L; Reutelingsperger CP
Cell Mol Life Sci; 2007 Nov; 64(22):2859-62. PubMed ID: 17876516
[TBL] [Abstract][Full Text] [Related]
3. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches.
Kenis H; van Genderen H; Deckers NM; Lux PA; Hofstra L; Narula J; Reutelingsperger CP
Exp Cell Res; 2006 Apr; 312(6):719-26. PubMed ID: 16380116
[TBL] [Abstract][Full Text] [Related]
4. Annexin A5-functionalized liposomes for targeting phosphatidylserine-exposing membranes.
Garnier B; Bouter A; Gounou C; Petry KG; Brisson AR
Bioconjug Chem; 2009 Nov; 20(11):2114-22. PubMed ID: 19835411
[TBL] [Abstract][Full Text] [Related]
5. Annexin A5 as a targeting agent for cancer treatment.
Woodward A; Faria GNF; Harrison RG
Cancer Lett; 2022 Oct; 547():215857. PubMed ID: 35940392
[TBL] [Abstract][Full Text] [Related]
6. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry.
Kenis H; van Genderen H; Bennaghmouch A; Rinia HA; Frederik P; Narula J; Hofstra L; Reutelingsperger CP
J Biol Chem; 2004 Dec; 279(50):52623-9. PubMed ID: 15381697
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.
Ungethüm L; Chatrou M; Kusters D; Schurgers L; Reutelingsperger CP
PLoS One; 2014; 9(5):e96749. PubMed ID: 24801051
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
[TBL] [Abstract][Full Text] [Related]
9. Thrombogenic role of cells undergoing apoptosis.
Wang J; Weiss I; Svoboda K; Kwaan HC
Br J Haematol; 2001 Nov; 115(2):382-91. PubMed ID: 11703340
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine targeting for diagnosis and treatment of human diseases.
Schutters K; Reutelingsperger C
Apoptosis; 2010 Sep; 15(9):1072-82. PubMed ID: 20440562
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylserine: A cancer cell targeting biomarker.
Sharma B; Kanwar SS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
[TBL] [Abstract][Full Text] [Related]
12. The role of annexin A5 in the modulation of the immune response against dying and dead cells.
Munoz LE; Frey B; Pausch F; Baum W; Mueller RB; Brachvogel B; Poschl E; Rödel F; von der Mark K; Herrmann M; Gaipl US
Curr Med Chem; 2007; 14(3):271-7. PubMed ID: 17305532
[TBL] [Abstract][Full Text] [Related]
13. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.
van Genderen HO; Kenis H; Hofstra L; Narula J; Reutelingsperger CP
Biochim Biophys Acta; 2008 Jun; 1783(6):953-63. PubMed ID: 18334229
[TBL] [Abstract][Full Text] [Related]
14. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells.
Li L; Zou J; Dai Y; Fan W; Niu G; Yang Z; Chen X
Nat Biomed Eng; 2020 Nov; 4(11):1102-1116. PubMed ID: 32807941
[TBL] [Abstract][Full Text] [Related]
15. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
Dasgupta SK; Guchhait P; Thiagarajan P
Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
17. Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
Ungethüm L; Kenis H; Nicolaes GA; Autin L; Stoilova-McPhie S; Reutelingsperger CP
J Biol Chem; 2011 Jan; 286(3):1903-10. PubMed ID: 21078669
[TBL] [Abstract][Full Text] [Related]
18. Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes.
Janko C; Jeremic I; Biermann M; Chaurio R; Schorn C; Muñoz LE; Herrmann M
Phys Biol; 2013 Dec; 10(6):065006. PubMed ID: 24304966
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sperm production in mice by annexin V microinjected into seminiferous tubules: possible etiology of phagocytic clearance of apoptotic spermatogenic cells and male infertility.
Maeda Y; Shiratsuchi A; Namiki M; Nakanishi Y
Cell Death Differ; 2002 Jul; 9(7):742-9. PubMed ID: 12058279
[TBL] [Abstract][Full Text] [Related]
20. FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5.
Engelke H; Lippok S; Dorn I; Netz RR; Rädler JO
J Phys Chem B; 2011 Nov; 115(44):12963-70. PubMed ID: 21954889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
